Recent studies have described the potential of TNIK as an anti-cancer target to inhibit Wnt signaling in several types of human cancers [4, 6–11] and TNIK inhibitors have been developed to treat Wnt-active cancers, but more experimental evidence is needed to elucidate the mechanism underlying the inhibition of proliferation in cancers. Here, TNIK is linked to cancer.